Stay updated with breaking news from Uzma Choudry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company aims to enable the cost-effective, reliable, and rapid development of new cell therapies.Stem cells unlock a range of treatment possibilities that have not previously been available to patients. While current treatment options rely on the
CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a £7.6 million seed round.
Meet the most active investors in the European techbio scene — a challenging but rewarding sector for the VCs that are able to get into it
There are many biotech hubs emerging across the UK, with Bristol’s Science Creates network being one thriving example.